As of Aug 28
| +0.0009 / +0.12%|
The 1 analysts offering 12-month price forecasts for Implant Sciences Corp have a median target of 1.75, with a high estimate of 1.75 and a low estimate of 1.75. The median estimate represents a +133.33% increase from the last price of 0.75.
The current consensus among 1 polled investment analysts is to Buy stock in Implant Sciences Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.